Skip to main content

News

Press release year list 2022 2021 2020
09/02/2021
Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance
08/02/2021
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
07/12/2021
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
07/01/2021
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
05/10/2021
Forte Biosciences, Inc. Announces First Quarter 2021 Results and Provides a General Business Update
05/03/2021
Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update
03/24/2021
Forte Biosciences, Inc. Announces 4Q and Full Year 2020 Results and Provides a General Business Update
03/17/2021
Forte Biosciences, Inc. to Announce 4Q and Full Year 2020 Results and Provide a General Business Update
02/23/2021
Forte Biosciences, Inc. to Present at the Chardan Annual Microbiome Medicines Summit on March 8th
02/18/2021
Forte Biosciences, Inc. to Present at the Cowen Annual Health Care Conference on March 1st
02/12/2021
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules